Clinical trialPhase 1
STX-1150 (Tune/CasX epigenetic PCSK9 silencing), first-in-human
NCT07428473
Open-label single-ascending-dose с expansion, план до 64 взрослых с повышенным LDL.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT07428473
Original sources
Details
- Phase
- Phase 1
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.